Search results
Results From The WOW.Com Content Network
340B Drug Pricing Program. The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal ...
The Kennedy Krieger Institute (/ ˈ k r iː ɡ ər /) is a nonprofit, 501(c)(3) tax-exempt, Johns Hopkins affiliate located in Baltimore, Maryland, that provides in-patient and out-patient medical care, community services, and school-based programs for children and adolescents with learning disabilities, as well as disorders of the brain, spinal cord, and musculoskeletal system.
UC Davis is also one of only 41 U.S. cancer centers to have earned the NCI's prestigious “comprehensive” designation, reserved for fewer than 1 percent of cancer centers nationwide. The center offers patients access to more than 150 clinical trials at any given time through a research program that includes more than 280 scientists.
On par with cancer–and yet the U.S. still does not have a single FDA-approved medication for treating long COVID. “This must change,” Al-Aly told HELP committee chair Sen. Bernie Sanders (I ...
The program provides up to a $9.25 monthly discount on service for eligible subscribers and up to $34.25 per month for those on Tribal lands ($111 and $411 savings a year respectively).
Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.
(Reuters) -A U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to cover preventive care services like cancer screenings and HIV-preventing medication at no ...
ACS CAN works to make cancer a national priority. Specifically, it advocates for better access to care, cancer prevention and early detection programs, cancer research funding, regulation of tobacco by the U.S. Food and Drug Administration, better quality of life for cancer patients, and attempts to raise awareness of and reduce cancer disparities.